Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doron Merims

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Parkinsonism & Related Disorders|November 9, 2007
Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's diseaseDoron Merims, Nir Giladi
The Israel Medical Association Journal : IMAJ|September 12, 2023
Rethinking Syringe Feeding in Advanced DementiaDoron Merims, Tania Boguslavsky
International Review of Psychiatry (Abingdon, England)|October 18, 2008
Cognitive and behavioural impairment in Parkinson's diseaseDoron Merims, Morris Freedman
Clinical Neuropharmacology|August 5, 2003
Waiting for ON: a major problem in patients with Parkinson disease and ON/OFF motor fluctuationsDoron Merims, Ruth Djaldetti, Eldad Melamed
Acta Neuropsychiatrica|March 9, 2016
Suicidal thoughts in patients with Parkinson's disease treated by deep brain stimulation of the subthalamic nuclei: two case reports and review of the literatureYacov Balash, Doron Merims, Nir Giladi
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|February 8, 2018
The clock-drawing test: normative data in adult and elderly Israeli ArabsDoron Merims, Merav Ben Natan, Deep Milawi, et al.
Harefuah|March 24, 2021
[DOES SCREENING FOR DEPRESSION AS A QUALITY MEASUREMENT IMPACT DIAGNOSIS RATE OF DEPRESSION IN PATIENTS UNDERGOING REHABILITATION FOLLOWING A STROKE]Doron Merims, Irina Seleznev, Giora Ben Ari, et al.
Clinical Neuropharmacology|November 11, 2006
Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosisDoron Merims, Meirav Balas, Chava Peretz, et al.
Clinical Neuropharmacology|February 5, 2003
Effect of late initiation of levodopa treatment in patients with long-standing Parkinson's diseaseRuth Djaldetti, Therese A Treves, Doron Merims, et al.
Journal of Molecular Neuroscience : MN|November 1, 2003
Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cellsYossef S Levy, Doron Merims, Hanna Panet, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Parkinsonism & Related Disorders|November 9, 2007
Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's diseaseDoron Merims, Nir Giladi
The Israel Medical Association Journal : IMAJ|September 12, 2023
Rethinking Syringe Feeding in Advanced DementiaDoron Merims, Tania Boguslavsky
International Review of Psychiatry (Abingdon, England)|October 18, 2008
Cognitive and behavioural impairment in Parkinson's diseaseDoron Merims, Morris Freedman
Clinical Neuropharmacology|August 5, 2003
Waiting for ON: a major problem in patients with Parkinson disease and ON/OFF motor fluctuationsDoron Merims, Ruth Djaldetti, Eldad Melamed
Acta Neuropsychiatrica|March 9, 2016
Suicidal thoughts in patients with Parkinson's disease treated by deep brain stimulation of the subthalamic nuclei: two case reports and review of the literatureYacov Balash, Doron Merims, Nir Giladi
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|February 8, 2018
The clock-drawing test: normative data in adult and elderly Israeli ArabsDoron Merims, Merav Ben Natan, Deep Milawi, et al.
Harefuah|March 24, 2021
[DOES SCREENING FOR DEPRESSION AS A QUALITY MEASUREMENT IMPACT DIAGNOSIS RATE OF DEPRESSION IN PATIENTS UNDERGOING REHABILITATION FOLLOWING A STROKE]Doron Merims, Irina Seleznev, Giora Ben Ari, et al.
Clinical Neuropharmacology|November 11, 2006
Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosisDoron Merims, Meirav Balas, Chava Peretz, et al.
Clinical Neuropharmacology|February 5, 2003
Effect of late initiation of levodopa treatment in patients with long-standing Parkinson's diseaseRuth Djaldetti, Therese A Treves, Doron Merims, et al.
Journal of Molecular Neuroscience : MN|November 1, 2003
Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cellsYossef S Levy, Doron Merims, Hanna Panet, et al.
Pageof 2